The EU and UK regions have stringent Pharmacovigilance and regulatory requirements such as electronic and expedited submissions of ICSRs, PSURs/PBRERs, robust signal management and risk management systems and real time effectiveness of risk minimization strategies. Learn more about how we support the Biopharma companies in managing their pharmacovigilance and drug safety activities right from the clinical phases of trials to the post-marketing and through the entire product lifecycle.